Bozzo J, Hernández M R, Ordinas A
Servei d'Hemoteràpia i Hemostàsia, Hospital Clínic i Provincial, Villarroel, Barcelona, Spain.
Cardiovasc Res. 1995 Nov;30(5):725-30.
To explore the role of blood flow in red blood cell deformability and determine whether it is associated with the release of ATP by red cells.
A perfusion system was employed to mimic the blood flow conditions. Red cell treatment in vitro with dipyridamole or aspirin, either alone or combined, was performed either on red cells alone prior to blood reconstitution or on already reconstituted blood. Blood viscosity at shear rates of 90 and 450 s-1 was measured, before and after perfusion, by means of a cone/plate viscometer. Red cell deformability was estimated as the magnitude of the slope between these two values of viscosity. ATP level in platelet-free plasma was measured by the firefly luciferase assay, and was used to monitor dipyridamole-induced blockade of ATP efflux by red cells.
In control experiments, red cells became more rigid after perfusion (slope values: 0.62 +/- 0.09 vs 0.40 +/- 0.04; P < 0.05). Absence of platelets or treatment of red cells with aspirin and/or dipyridamole prevented dipyridamole prevented the increased stiffness of red cells observed after exposure of blood to flow conditions. Moreover, a significant increase in red cell deformability was observed when blood was treated with dipyridamole alone or combined with aspirin (0.69 +/- 0.07 and 0.65 +/- 0.05 respectively vs. 0.40 +/- 0.04; P < 0.05). Treatment with dipyridamole alone or combined with aspirin caused a decrease in ATP levels. Statistical significance was reached when red cells alone were treated with dipyridamole alone (45.8 +/- 2.8 vs. 173.3 +/- 47.6 ng ATP/ml; P < 0.05).
Flow stress induced a decrease in red cell deformability probably linked to platelet activation. Treatment with dipyridamole alone or associated with aspirin eliminated the effect of flow, increasing red cell deformability. Under our experimental conditions, modifications could not be ascribed to red cell-released ATP. Our results emphasize the importance of blood flow conditions to evaluate RBC deformability.
探讨血流在红细胞变形性中的作用,并确定其是否与红细胞释放ATP有关。
采用灌注系统模拟血流条件。在血液重构前单独对红细胞进行处理,或对已重构的血液进行处理,用双嘧达莫或阿司匹林单独或联合处理体外红细胞。在灌注前后,通过锥板粘度计测量剪切速率为90和450 s-1时的血液粘度。红细胞变形性通过这两个粘度值之间斜率的大小来估计。通过萤火虫荧光素酶测定法测量无血小板血浆中的ATP水平,并用于监测双嘧达莫诱导的红细胞ATP外排阻断。
在对照实验中,灌注后红细胞变得更僵硬(斜率值:0.62±0.09对0.40±0.04;P<0.05)。缺乏血小板或用阿司匹林和/或双嘧达莫处理红细胞可防止双嘧达莫防止血液暴露于流动条件后观察到的红细胞硬度增加。此外,当血液单独用双嘧达莫或与阿司匹林联合处理时,观察到红细胞变形性显著增加(分别为0.69±0.07和0.65±0.05对0.40±0.04;P<0.05)。单独用双嘧达莫或与阿司匹林联合处理导致ATP水平降低。当单独用双嘧达莫处理红细胞时达到统计学显著性(45.8±2.8对173.3±47.6 ng ATP/ml;P<0.05)。
流动应力导致红细胞变形性降低,可能与血小板活化有关。单独用双嘧达莫或与阿司匹林联合处理可消除流动的影响,增加红细胞变形性。在我们的实验条件下,变化不能归因于红细胞释放的ATP。我们的结果强调了血流条件对评估红细胞变形性的重要性。